The quick answer
XERF uses dual-frequency monopolar radiofrequency; Ultherapy uses microfocused ultrasound with real-time imaging. Those are meaningful differences in energy delivery and treatment planning. They do not prove which gives you the better result. Ultherapy's imaging is a concrete feature to discuss; XERF's adjustable RF protocol is another. Start with the clinician's explanation of your concern, then compare the exact plans and their evidence.
At a glance
| What matters | XERF | Ultherapy / PRIME |
|---|---|---|
| Energy | Monopolar RF: 6.78 MHz and 2 MHz | Microfocused ultrasound |
| Planning feature | Adjustable RF protocol and cooling | Real-time ultrasound visualization |
| Application | External applicator; no microneedles | External transducer; no microneedles |
| Evidence discussed here | 39-person uncontrolled study of two visits | Established ultrasound device family; confirm the generation |
| Quantity on a quote | Shots, treated area and visits | Lines, transducers, treated area and visits |
Sources for the comparison: Cynosure: XERF specifications and manufacturer claims · Weiss et al., 2026: dual-frequency monopolar RF study · Merz: Ultherapy / PRIME technology and safety information
RF and ultrasound are different tools
Cynosure describes XERF's two RF frequencies and adjustable treatment settings. Merz describes Ultherapy's microfocused ultrasound and visualization, with transducers designed for different treatment depths. Confirm whether the clinic offers the original Ultherapy system or PRIME; a generic 'HIFU' listing is not enough.
Our editorial take: ask for the reasoning behind the tool. If visualization is central to the doctor's plan, have them explain what it changes about treatment placement. If an RF plan is proposed, ask what skin change is expected and why that protocol fits. A discussion of your anatomy is more useful than a diagram declaring a winner.
Read the evidence: Cynosure: XERF specifications and manufacturer claims · Merz: Ultherapy / PRIME technology and safety information
Deeper is a specification, not a result
Manufacturers describe depth and lifting in different ways. Do not convert those descriptions into a guarantee of a surgical-looking result or assume that treating deeper is always desirable. The Ultherapy page itself says its tissue illustrations are simplified and do not represent every energy device.
The XERF human study reviewed here did not directly measure human SMAS changes. Ultherapy's imaging feature also does not establish superiority over XERF by itself. Ask which outcome matters to you, which tissue is being targeted and what degree of visible change is realistic.
Read the evidence: Merz: Ultherapy / PRIME technology and safety information · Weiss et al., 2026: dual-frequency monopolar RF study
What the XERF study does — and does not — compare
The 2026 XERF study followed 39 completers after two visits four weeks apart, with assessment to 90 days after the second treatment. It had no Ultherapy control group, and investigator assessments were unblinded. The manufacturer supported the study, including the device and research services.
It provides an early human outcome signal for that protocol. It cannot establish that XERF lifts more, lasts longer or hurts less than Ultherapy. Older studies comparing other RF devices with ultrasound also should not be relabelled as a direct XERF-versus-PRIME trial.
Read the evidence: Weiss et al., 2026: dual-frequency monopolar RF study
The comfort question deserves a real answer
XERF is marketed as requiring no numbing, but the study reported mean pain of 4.2 out of 10 without topical anaesthesia. Ultherapy's manufacturer information lists pain among common trial side effects. Different studies, treatment plans and pain scales cannot supply a fair personal pain ranking.
Tell the clinician if discomfort is a major concern. Ask about the actual comfort plan, pauses, recovery and follow-up. Clarify previous fillers or energy treatments and ask about redness, swelling and other possible adverse effects. A short Seoul itinerary is a reason to plan carefully, not to accept a 'zero downtime' promise.
Read the evidence: Weiss et al., 2026: dual-frequency monopolar RF study · Merz: Ultherapy / PRIME technology and safety information · Ultherapy: instructions for use
Compare a course, not a shot count
A 600-shot RF offer and a 300-line ultrasound offer are different quantities. Their energy delivery, coverage and proposed visit counts may differ. Ask for each plan's complete price and rationale rather than calculating a price per shot across platforms.
The Ultherapy benchmark below is for its stated 300-line quantity. We have no verified XERF median, and the named XERF clinic example in our Thermage comparison is one advertised offer. Also confirm whether a PRIME upgrade, numbing, VAT or an additional visit changes the total.
Read the evidence: Glow Lab: price research methodology · Glow Lab: Korean event-price conditions
Current Seoul prices to compare
These are research options, not a personal treatment plan. Prices are medians of Korean event listings for the stated quantity; eligibility and extras vary. Read the price conditions.
Shots and ultrasound lines are not interchangeable doses. Match the device version, treated area, tip or cartridge, number of visits and final total. Glow Lab has no verified XERF or Volnewmer median yet; the available benchmark below is context for the named treatment only.
Ultherapy 300-line benchmark only; confirm the device generation and scope. It is not a matched XERF package.
Questions to take to the clinic
- Which problem do you see, and why does RF or ultrasound fit it?
- Is this Ultherapy or PRIME, and how will visualization inform the plan?
- What areas, tips or transducers and visits are included?
- Which human evidence supports the expected change with this exact protocol?
- What is the complete price and the comfort, recovery and follow-up plan?
Common questions
Is XERF better than Ultherapy?
The sources reviewed here do not establish that. The XERF study had no Ultherapy comparator. Device features and a clinician's individualized plan are worth comparing without declaring an unsupported winner.
Is XERF HIFU?
No. XERF is a monopolar radiofrequency platform. Ultherapy delivers microfocused ultrasound with visualization. Both use external applicators, but they deliver different energy.
Does XERF hurt less than Ultherapy?
We cannot establish a fair ranking from the sources here. XERF's no-numbing marketing does not mean painless. Ask about the specific settings, treated area and comfort plan rather than comparing pain scores from unrelated protocols.
Sources and scope
This is sourced editorial research, not a hands-on treatment review or an independent clinical trial. Device specifications and manufacturer claims are distinguished from human study findings. Study size, protocol and comparison groups limit what can be concluded. The practical trade-offs labelled as our editorial take are interpretations, not proven superiority. Medical suitability and travel clearance require the treating clinician's assessment.
Have a quote already?
Match the product, dose and treatment area, then see how the total compares with Korean event prices.
Check my quote